Targeting Cdk11 in osteosarcoma cells using the CRISPR‐cas9 system

E-ISSN： 1554-527x|33|2|199-207

ISSN： 0736-0266

Source： JOURNAL OF ORTHOPAEDIC RESEARCH, Vol.33, Iss.2, 2015-02, pp. : 199-207

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Revolutionizing male fertility factor research in mice by using the genome editing tool CRISPR/Cas9

Reproductive Medicine and Biology, Vol. 17, Iss. 1, 2018-01 ,pp. : 3-10

John Wiley & Sons Inc

Access to resources Recommend Favorite

CRISPR-Cas9, cellules germinales et embryon humain

By Jouannet Pierre

Biologie Aujourd'hui, Vol. 211, Iss. 3, 2018-02 ,pp. : 207-213

Edp Sciences

Access to resources Recommend Favorite

CRISPR-Cas9, une nouvelle donne pour la thérapie génique

By Jordan Bertrand

Médecine/sciences, Vol. 31, Iss. 11, 2015-11 ,pp. : 1035-1038

Edp Sciences

Access to resources Recommend Favorite

The CRISPR/Cas system inhibited the pro‐oncogenic effects of alternatively spliced fibronectin extra domain A via editing the genome in salivary adenoid cystic carcinoma cells

ORAL DISEASES, Vol. 21, Iss. 5, 2015-07 ,pp. : 608-618

John Wiley & Sons Inc

Access to resources Recommend Favorite

P025: CRISPR/Cas9 nickase‐mediated inactivation of hepatitis B virus replication

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 31-31

John Wiley & Sons Inc

Access to resources Recommend Favorite